IRF8

IRF8 (Interferon Regulatory Factor 8) is a transcription factor that plays a crucial role in the regulation of the immune system. It is a member of the interferon regulatory factor family, which is involved in the regulation of interferon-inducible genes and the development of the immune system.
Function[edit]
IRF8 is primarily expressed in hematopoietic cells, including macrophages, dendritic cells, and B cells. It is essential for the development and function of these cells. IRF8 regulates the expression of genes involved in the innate immune response and the adaptive immune response.
In macrophages and dendritic cells, IRF8 is involved in the regulation of cytokine production and the activation of antigen presentation. It plays a critical role in the differentiation of monocytes into macrophages and dendritic cells, which are essential for the initiation of the immune response.
Role in Disease[edit]
Mutations or dysregulation of IRF8 can lead to various immune disorders. For example, IRF8 deficiency can result in impaired immune responses and increased susceptibility to infections. Conversely, overexpression of IRF8 has been associated with certain autoimmune diseases and hematological malignancies.
Mechanism of Action[edit]
IRF8 functions by binding to specific DNA sequences in the promoters of target genes, thereby regulating their transcription. It often forms complexes with other transcription factors, such as PU.1 and IRF1, to exert its effects on gene expression. These complexes can either activate or repress the transcription of genes involved in immune responses.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian